We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.
Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
One company to watch right now is CONMED (CNMD - Free Report) . CNMD is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with a P/E ratio of 14.19, which compares to its industry's average of 17.14. Over the past 52 weeks, CNMD's Forward P/E has been as high as 31.12 and as low as 13, with a median of 15.41.
We also note that CNMD holds a PEG ratio of 0.74. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. CNMD's PEG compares to its industry's average PEG of 1.94. Over the past 52 weeks, CNMD's PEG has been as high as 1.09 and as low as 0.51, with a median of 0.71.
Investors should also recognize that CNMD has a P/B ratio of 2.27. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 4.56. CNMD's P/B has been as high as 4.15 and as low as 2.05, with a median of 2.54, over the past year.
Finally, investors should note that CNMD has a P/CF ratio of 10.19. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. CNMD's P/CF compares to its industry's average P/CF of 18.44. CNMD's P/CF has been as high as 24.89 and as low as 9.19, with a median of 13.12, all within the past year.
Another great Medical - Dental Supplies stock you could consider is McKesson (MCK - Free Report) , which is a # 2 (Buy) stock with a Value Score of A.
Shares of McKesson are currently trading at a forward earnings multiple of 16.24 and a PEG ratio of 1.15 compared to its industry's P/E and PEG ratios of 17.14 and 1.94, respectively.
MCK's price-to-earnings ratio has been as high as 19.54 and as low as 14.23, with a median of 16.92, while its PEG ratio has been as high as 1.65 and as low as 1.06, with a median of 1.32, all within the past year.
McKesson also has a P/B ratio of -27.89 compared to its industry's price-to-book ratio of 4.56. Over the past year, its P/B ratio has been as high as -23.17, as low as -59.19, with a median of -41.94.
Value investors will likely look at more than just these metrics, but the above data helps show that CONMED and McKesson are likely undervalued currently. And when considering the strength of its earnings outlook, CNMD and MCK sticks out as one of the market's strongest value stocks.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Should Value Investors Buy CONMED (CNMD) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.
Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.
One company to watch right now is CONMED (CNMD - Free Report) . CNMD is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with a P/E ratio of 14.19, which compares to its industry's average of 17.14. Over the past 52 weeks, CNMD's Forward P/E has been as high as 31.12 and as low as 13, with a median of 15.41.
We also note that CNMD holds a PEG ratio of 0.74. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. CNMD's PEG compares to its industry's average PEG of 1.94. Over the past 52 weeks, CNMD's PEG has been as high as 1.09 and as low as 0.51, with a median of 0.71.
Investors should also recognize that CNMD has a P/B ratio of 2.27. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 4.56. CNMD's P/B has been as high as 4.15 and as low as 2.05, with a median of 2.54, over the past year.
Finally, investors should note that CNMD has a P/CF ratio of 10.19. This metric takes into account a company's operating cash flow and can be used to find stocks that are undervalued based on their solid cash outlook. CNMD's P/CF compares to its industry's average P/CF of 18.44. CNMD's P/CF has been as high as 24.89 and as low as 9.19, with a median of 13.12, all within the past year.
Another great Medical - Dental Supplies stock you could consider is McKesson (MCK - Free Report) , which is a # 2 (Buy) stock with a Value Score of A.
Shares of McKesson are currently trading at a forward earnings multiple of 16.24 and a PEG ratio of 1.15 compared to its industry's P/E and PEG ratios of 17.14 and 1.94, respectively.
MCK's price-to-earnings ratio has been as high as 19.54 and as low as 14.23, with a median of 16.92, while its PEG ratio has been as high as 1.65 and as low as 1.06, with a median of 1.32, all within the past year.
McKesson also has a P/B ratio of -27.89 compared to its industry's price-to-book ratio of 4.56. Over the past year, its P/B ratio has been as high as -23.17, as low as -59.19, with a median of -41.94.
Value investors will likely look at more than just these metrics, but the above data helps show that CONMED and McKesson are likely undervalued currently. And when considering the strength of its earnings outlook, CNMD and MCK sticks out as one of the market's strongest value stocks.